ValueMarkers

One plan. It pays for work, not access.

US-listed companies, and a nightly monitoring service that runs on your behalf whether or not you log in.

Yearly

Best value

$228USD a year

$19 a month, billed yearly. Save 34%.

Start free trial →

Monthly

$29USD a month

Cancel any time

Start free trial →

The trial

14 days, card required. First charge on day 15; cancel before then and pay nothing. Discount codes apply at checkout.

  • Source trail on every number for the few thousand companies: formula, inputs, filing date, mismatch badge
  • Guardrails re-tested nightly at 23:30 UTC, breach math attached
  • Piotroski, Altman and Beneish, computed as published and shown test by test
  • A DCF workbench: editable assumptions, saved diffable versions
  • Screening across thousands of listings, every result carrying its forensic scores and its evidence tier
  • Watchlists, a weekly brief, an inbox that stays quiet unless your reasons changed
  • Every figure dated, n/a where a number is missing, and a data-issue link that reaches a person

30 days, full refund. Cancel in one click, anytime. Miss an alert by more than a day and the last two months are refunded.

Fair questions

Which market does this cover?

United States only: NYSE, NASDAQ and AMEX. No coverage outside it.

How much of the universe has filed accounts behind it?

most, but not all, of the companies we list. Only those get a source trail, a recomputation and nightly monitoring; every other listing is marked by tier before you read a number.

What happens if I cancel?

One click, one question about why, no retention call. Nothing is charged during the trial; afterwards, access runs to the end of the period you paid for. Your theses, guardrails and watchlists stay exactly as you left them.

Is this investment advice?

No. ValueMarkers is a research tool and the judgment stays yours: a DCF fair value is arithmetic on assumptions you enter, a score is a percentile rank against the covered universe, and a verified figure opens into the filing behind it. Nothing here recommends buying or selling. Read the disclaimer.